Gastrointestinal symptoms are associated with trajectories of chemotherapy-induced nausea
- PMID: 31428931
- PMCID: PMC7028490
- DOI: 10.1007/s00520-019-05031-5
Gastrointestinal symptoms are associated with trajectories of chemotherapy-induced nausea
Abstract
Purpose: Between 19 and 58% of oncology patients experience chemotherapy-induced nausea (CIN). In a sample of outpatients with breast, gastrointestinal (GI), gynecological, and lung cancer, the study purposes were to evaluate for inter-individual differences in the severity of CIN over two cycles of chemotherapy (CTX) and to determine which demographic and clinical characteristics and GI symptoms were associated with higher initial levels as well as with the trajectories of CIN severity.
Methods: Patients completed study questionnaires at six time points over two cycles of CTX. These questionnaires provided information on demographic and clinical characteristics, as well as the occurrence of twelve GI symptoms. Hierarchical linear modeling based on full maximum likelihood estimation was performed.
Results: Of the 1251 patients, 47.2% reported CIN. Across two cycles of CTX, lower functional status scores and higher levels of comorbidity were associated with higher initial levels of CIN. Younger age and emetogenicity of the CTX regimen were associated with higher initial levels as well as worse trajectories of CIN. The occurrence of five GI symptoms (i.e., vomiting, lack of appetite, constipation, feeling bloated, and difficulty swallowing) was associated with higher initial levels of CIN. The occurrence of mouth sores was associated with higher initial levels as well as with worst trajectories of CIN.
Conclusions: This study is the first to identify distinct demographic, clinical, and GI symptom characteristics associated with CIN severity. These findings suggest that the etiology of CIN is complex and may warrant interventions beyond standard antiemetics.
Keywords: Antiemetics; Cancer; Chemotherapy; Gastrointestinal symptoms; Hierarchical linear modeling; Nausea.
Figures




Similar articles
-
Neuropsychological Symptoms and Intrusive Thoughts Are Associated With Worse Trajectories of Chemotherapy-Induced Nausea.J Pain Symptom Manage. 2020 Mar;59(3):668-678. doi: 10.1016/j.jpainsymman.2019.10.023. Epub 2019 Nov 2. J Pain Symptom Manage. 2020. PMID: 31689477 Free PMC article.
-
Distinct Nausea Profiles Are Associated With Gastrointestinal Symptoms in Oncology Patients Receiving Chemotherapy.Cancer Nurs. 2023 Mar-Apr 01;46(2):92-102. doi: 10.1097/NCC.0000000000001076. Epub 2022 Mar 4. Cancer Nurs. 2023. PMID: 35671438 Free PMC article.
-
Multiple Gastrointestinal Symptoms Are Associated With Chemotherapy-Induced Nausea in Patients With Breast Cancer.Cancer Nurs. 2022 May-Jun 01;45(3):181-189. doi: 10.1097/NCC.0000000000000976. Cancer Nurs. 2022. PMID: 34183520 Free PMC article.
-
Metagenomics and chemotherapy-induced nausea: A roadmap for future research.Cancer. 2022 Feb 1;128(3):461-470. doi: 10.1002/cncr.33892. Epub 2021 Oct 13. Cancer. 2022. PMID: 34643945 Free PMC article. Review.
-
Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists.Support Care Cancer. 2017 May;25(5):1661-1671. doi: 10.1007/s00520-017-3585-z. Epub 2017 Jan 20. Support Care Cancer. 2017. PMID: 28108820 Free PMC article. Review.
Cited by
-
Perturbations in Endocytotic and Apoptotic Pathways Are Associated With Chemotherapy-Induced Nausea.Biol Res Nurs. 2021 Apr;23(2):238-247. doi: 10.1177/1099800420951271. Epub 2020 Aug 20. Biol Res Nurs. 2021. PMID: 32815385 Free PMC article.
-
Cachexia Anorexia Syndrome and Associated Metabolic Dysfunction in Peritoneal Metastasis.Int J Mol Sci. 2019 Oct 31;20(21):5444. doi: 10.3390/ijms20215444. Int J Mol Sci. 2019. PMID: 31683709 Free PMC article. Review.
-
Relationship between nausea and vomiting and physical activity in patients with lung cancer undergoing first chemotherapy.Front Oncol. 2024 Jul 24;14:1396637. doi: 10.3389/fonc.2024.1396637. eCollection 2024. Front Oncol. 2024. PMID: 39114312 Free PMC article.
-
Gastrointestinal Symptom Cluster is Associated With Epigenetic Regulation of Lymphotoxin Beta in Oncology Patients Receiving Chemotherapy.Biol Res Nurs. 2023 Jan;25(1):51-64. doi: 10.1177/10998004221115863. Epub 2022 Aug 5. Biol Res Nurs. 2023. PMID: 35929442 Free PMC article.
-
Antitumoral Agent-Induced Constipation: A Systematic Review.Cancers (Basel). 2023 Dec 24;16(1):99. doi: 10.3390/cancers16010099. Cancers (Basel). 2023. PMID: 38201526 Free PMC article. Review.
References
-
- Aouizerat BE, Dodd M, Lee K, West C, Paul SM, Cooper BA, Wara W, Swift P, Dunn LB, Miaskowski C (2009) Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue Biol Res Nurs 11: 27–41 - PubMed
-
- Bowen JM, White I, Smith L, Tsykin A, Kristaly K, Thompson SK, Karapetis CS, Tan H, Game PA, Irvine T, Hussey DJ, Watson DI, Keefe DM (2015) Pre-therapy mRNA expression of TNF is associated with regimen-related gastrointestinal toxicity in patients with esophageal cancer: a pilot study Support Care Cancer 23: 3165–3172 - PubMed
-
- Donovan HS, Hagan TL, Campbell GB, Boisen MM, Rosenblum LM, Edwards RP, Bovbjerg DH, Horn CC (2016) Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysis Support Care Cancer 24: 2635–2642 - PMC - PubMed